Farallon Capital to Wage Proxy Battle at Biotech Firm
Farallon has nominated three directors to the board of Exelixis, which develops cancer-fighting drugs.
Source link
Farallon has nominated three directors to the board of Exelixis, which develops cancer-fighting drugs.
Source link